Based on a small sample size, BTZ-043 is a promising antituberculosis drug candidate with favourable safety and good bactericidal activity. Larger follow-up studies are needed to detect any less ...

Tuberculosis has plagued mankind since ancient times, and the struggle between humans and tuberculosis continues. Mycobacterium tuberculosis is the leading cause of tuberculosis, infecting nearly ...

ABSTRACT: Introduction: Resistance to antituberculosis drugs and adverse drug reactions remain the leading causes of tuberculosis therapeutic failure globally. Despite the increasing acceptance of ...

In an effort to develop potent new antituberculosis agents that would be effective against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis, we prepared a novel series of ...

New Delhi:In a significant move to ensure adequate availability, invoking para 3 of the Drugs (Prices Control) Order, 2013, the National Pharmaceutical Pricing Authority (NPPA) has directed Macleods ...

Adrenocortical function before and after antituberculosis treatment. We found a lower baseline serum cortisol in patients with EPTB compared with controls, although none had adrenal insufficiency. We ...

In the World Journal of Clinical Cases, Xiu and colleagues presented the rare case report of a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria (AA-PNH) syndrome who underwent leukemic ...

The current standard treatment for tuberculosis (TB) consists of a combination of four antibiotics administered for 6 to 12 months. There is hence a clear need for new strategies both for shorter ...

Treatment usually involves 6 months of antituberculosis medication. The cure rate is around 90%, with early detection and drug compliance. Keep reading to learn more about GUTB, including the ...